BioXcel Therapeutics, Inc. - stock earnings
BTAI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -50.5 million USD | 341000 USD |
| 2023Q2 | -53.5 million USD | 457000 USD |
| 2023Q1 | -51.0 million USD | 206000 USD |
| 2022Q4 | -58.1 million USD | 238000 USD |
| 2022Q3 | -44.6 million USD | 137000 USD |
| 2022Q2 | -39.1 million USD | ? USD |
| 2022Q1 | -31.5 million USD | ? USD |
| 2021Q4 | -26.1 million USD | ? USD |
| 2021Q3 | -26.8 million USD | 14879 USD |
| 2021Q2 | -27.6 million USD | 14104 USD |
| 2021Q1 | -26.4 million USD | 11638 USD |
| 2020Q4 | -21.1 million USD | 0 USD |
| 2020Q3 | -24.8 million USD | 0 USD |
| 2020Q2 | -21.4 million USD | ? USD |
| 2020Q1 | -14.9 million USD | ? USD |
| 2019Q4 | -8.3 million USD | ? USD |
| 2019Q3 | -9.0 million USD | ? USD |
| 2019Q2 | -8.5 million USD | ? USD |
| 2019Q1 | -7.2 million USD | ? USD |
| 2018Q4 | -7.1 million USD | ? USD |
| 2018Q3 | -4.9 million USD | ? USD |
| 2018Q2 | -3.0 million USD | ? USD |
| 2018Q1 | -4.3 million USD | ? USD |
| 2017Q4 | -2.5 million USD | ? USD |
| 2017Q3 | -917000 USD | ? USD |
| 2017Q2 | -565000 USD | ? USD |
| 2017Q1 | -529000 USD | ? USD |
| 2016Q4 | -2.1 million USD | ? USD |
BTAI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -211.6 million USD | 1.2 million USD |
| 2022 | -171.8 million USD | 375000 USD |
| 2021 | -106.6 million USD | ? USD |
| 2020 | -82.0 million USD | 24 USD |
| 2019 | -32.3 million USD | ? USD |
| 2018 | -19.3 million USD | ? USD |
| 2017 | -4.5 million USD | ? USD |
| 2016 | -2.1 million USD | ? USD |
| 2015 | -636000 USD | ? USD |
BTAI
Price: $2.63
52 week price:
Earnings Per Share: -6.15 USD
P/E Ratio: -0.51
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 510800
Market Capitalization: 80.4 million